Nexien Biopharma Pink Sheet Forecast - Simple Moving Average

NXEN Stock  USD 0.01  0.01  25.00%   
The Simple Moving Average forecasted value of Nexien Biopharma on the next trading day is expected to be 0.02 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.33. Nexien Pink Sheet Forecast is based on your current time horizon.
  
A two period moving average forecast for Nexien Biopharma is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

Nexien Biopharma Simple Moving Average Price Forecast For the 24th of November

Given 90 days horizon, the Simple Moving Average forecasted value of Nexien Biopharma on the next trading day is expected to be 0.02 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.000087, and the sum of the absolute errors of 0.33.
Please note that although there have been many attempts to predict Nexien Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Nexien Biopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Nexien Biopharma Pink Sheet Forecast Pattern

Backtest Nexien BiopharmaNexien Biopharma Price PredictionBuy or Sell Advice 

Nexien Biopharma Forecasted Value

In the context of forecasting Nexien Biopharma's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Nexien Biopharma's downside and upside margins for the forecasting period are 0.0001 and 34.86, respectively. We have considered Nexien Biopharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.01
0.0001
Downside
0.02
Expected Value
34.86
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Nexien Biopharma pink sheet data series using in forecasting. Note that when a statistical model is used to represent Nexien Biopharma pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria105.0856
BiasArithmetic mean of the errors 1.0E-4
MADMean absolute deviation0.0056
MAPEMean absolute percentage error0.2315
SAESum of the absolute errors0.3297
The simple moving average model is conceptually a linear regression of the current value of Nexien Biopharma price series against current and previous (unobserved) value of Nexien Biopharma. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for Nexien Biopharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nexien Biopharma. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nexien Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.0234.76
Details
Intrinsic
Valuation
LowRealHigh
0.000.0134.75
Details

Other Forecasting Options for Nexien Biopharma

For every potential investor in Nexien, whether a beginner or expert, Nexien Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Nexien Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Nexien. Basic forecasting techniques help filter out the noise by identifying Nexien Biopharma's price trends.

Nexien Biopharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nexien Biopharma pink sheet to make a market-neutral strategy. Peer analysis of Nexien Biopharma could also be used in its relative valuation, which is a method of valuing Nexien Biopharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Nexien Biopharma Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Nexien Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Nexien Biopharma's current price.

Nexien Biopharma Market Strength Events

Market strength indicators help investors to evaluate how Nexien Biopharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nexien Biopharma shares will generate the highest return on investment. By undertsting and applying Nexien Biopharma pink sheet market strength indicators, traders can identify Nexien Biopharma entry and exit signals to maximize returns.

Nexien Biopharma Risk Indicators

The analysis of Nexien Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Nexien Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nexien pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Nexien Biopharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nexien Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexien Biopharma will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Nexien Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nexien Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nexien Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nexien Biopharma to buy it.
The correlation of Nexien Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nexien Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nexien Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nexien Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Nexien Pink Sheet

Nexien Biopharma financial ratios help investors to determine whether Nexien Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nexien with respect to the benefits of owning Nexien Biopharma security.